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Streptococcal pyrogenic exotoxin B is an extracellular
cysteine protease. Only nephritis-associated strains
of group A streptococci secrete this protease and this may be
involved in the pathogenesis of post-streptococcal
glomerulonephritis. Mice were actively immunized with a
recombinant protease inactive exotoxin B mutant or
passively immunized with exotoxin B antibody.
Characteristics of glomerulonephritis were measured using
histology, immunoglobulin deposition, complement
activation, cell infiltration, and proteinuria. None of the mice
given bovine serum albumin or exotoxin A as controls
showed any marked changes. Immunoglobulin deposition,
complement activation, and leukocyte infiltration occurred
only in the glomeruli of exotoxin B-hyperimmunized mice.
One particular anti-exotoxin B monoclonal antibody, 10G,
was cross-reactive with kidney endothelial cells and it caused
kidney injury and proteinuria when infused into mice.
This cross-reactivity may be involved in the pathogenesis
of glomerulonephritis following group A streptococcal
infection.
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Group A streptococcus (GAS) causes a wide spectrum of
diseases, ranging in severity from mild pharyngitis, impetigo,
and scarlet fever to life-threatening diseases, including
necrotizing fasciitis and streptococcal toxic shock syndrome.
Nonsuppurative sequelae, such as rheumatic heart disease
and acute post-streptococcal glomerulonephritis (APSGN),
may also occur.1,2 An immune-complex pathogenesis is
thought to be involved in rheumatic heart disease and
APSGN following GAS infections. GAS antigens deposit in
glomeruli and recruit antibodies and complements. Mole-
cular mimicry between streptococcal and renal antigens may
also be involved in the development of APSGN. Early studies
suggested a role for certain M protein serotypes in APSGN
pathogenesis.2–4 In recent years, other antigens have attracted
attention, including streptococcal pyrogenic exotoxin B and
its precursor form (SPE B/zymogen),5–8 streptokinase,9,10 and
glyceraldehyde-3-phosphate dehydrogenase (NAPlr), a nephri-
tis-associated plasmin receptor.11–14 Either nephritogenic
antigens or their antibodies, or both, was found within
glomerular deposits in the kidney biopsies of APSGN patients.
SPE B, which functions as a cysteine protease, is expressed
as a 40-kDa precursor and is subsequently cleaved to a 28-
kDa molecule. SPE B cleaved several host factors, such as
fibronectin, vitronectin, fibrinogen, immunoglobulin G (IgG),
and the interleukin-1b precursor to the interleukin-1b active
form.15 SPE B was detected in kidney biopsies using an
indirect immunofluorescence technique, which showed that
12 of 18 (67%) APSGN patients were positive for SPE B,
whereas only 4 of 25 (16%) of non-APSGN biopsies were
positive.7 A recent study5 also demonstrated glomerular
deposits of SPE B in 12 of 17 APSGN biopsies. In addition,
antibody titers of SPE B/zymogen were higher than antibody
titers of other GAS antigens, including glyceraldehyde-3-
phosphate dehydrogenase, streptolysin O, and DNase B, in
APSGN patient sera.5,8
We established previously a mouse model of GAS
infection showing the pathogenic role of SPE B in tissue
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damage and bacterial dissemination.16,17 In this study,
we investigated the mechanisms involved in the post-
infection sequelae. A mouse glomerulonephritis model was
induced using active immunization with recombinant SPE B
mutant C192S. In these hyperimmunized mice, we found
renal pathologic changes and proteinuria. By generating and
screening monoclonal anti-SPE B antibodies, we found that
one clone, 10G, was cross-reactive with endothelial cells. We
also found that 10G antibody caused kidney injuries in mice.
The endothelial cell membrane proteins recognized by anti-
SPE B sera and 10G antibody were identified.
RESULTS
Pathologic changes in the kidneys of SPE B-hyperimmunized
mice
Owing to the autocatalytic activity of wild-type SPE B, we
used protease-negative mutant 28-kDa C192S18 to immunize
mice. Lesions appeared in the kidneys of the mice after they
had been hyperimmunized with C192S. We found diffuse
glomerulonephritis (Figure 1a) and a different degree of
shrinkage of the glomerular tufts with necrotizing glomer-
ulonephritis (Figure 1b). Some of the glomeruli were
occupied by eosinophilic foamy substances in more than
half of Bowman’s space (Figure 1c). More advanced
glomerular lesions were characterized by marked shrinkage
of the glomerular tufts, and some of the severe glomerular
tufts almost disappeared (Figure 1d). We also found
moderately dilated tubules containing foamy eosinophilic
cast-like substances as well as some tubular degenerative
changes (Figure 1e and f). The severity of the main lesions in
the kidney after C192S hyperimmunization is summarized in
Table 1.
In the bovine serum albumin (BSA)- and SPE A-
immunized groups, there were no pathologic lesions in the
kidneys (data not shown). Advanced glomerular lesions were
characterized by contracted tufts and thickening of the
capillary basement membranes (Figure 2e and f). The
glomerular basement membrane thickening was not observed
in the healthy control (Figure 2a and b) and in the BSA-
immunized groups (Figure 2c and d).
Immunoglobulin deposition, complement activation, and
leukocyte infiltration in mouse kidney glomeruli
One of the hallmarks of APSGN is a decrease in serum C3
complement levels.19 Complement C3 and IgG generally
appear as deposits in the glomeruli of APSGN patients.20
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Figure 1 | Histopathologic changes in the kidneys of mice hyperimmunized with 28-kDa SPE B mutant protein C192S. BALB/c
mice were hyperimmunized four times with C192S, and their kidney sections were stained with hematoxylin–eosin (n¼ 10 per group).
(a) Hyperimmunization with C192S caused diffuse glomerulonephritis lesions to appear (arrows). (b) Glomerular damage showed different
severity shrinkage of the glomerular tufts and necrotic glomerulonephritis (arrows). (c) Eosinophilic foamy substance occupied more than half
of Bowman’s space in the glomerulus (arrow). (d) In more advanced glomerular lesions, the severe glomerular tufts almost disappeared (arrow).
(e) Moderately dilated tubules containing eosinophilic cast-like substances (arrows) and some tubular degenerative changes were visible.
(f) Higher magnification of a tubule containing eosinophilic cast-like substances. (a) Bar¼ 100 mm, (b–f) Bar¼ 50 mm.
Table 1 | Main lesions in the kidney after C192S
hyperimmunization in BALB/c mice
Severity of main lesion
Mouse no. Glomerular tuft shrinkage Tubular cast
1 +++ +++
2 +++ +++
3 +++ +++
4  +
5  
6  +
7 +++ +++
8 + +
9 ++ +
10 + +
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APSGN is thought to be primarily associated with immune
complex deposits or complement activation secondary to
immune complex deposits. We found IgG deposits in the
glomeruli of C192S-immunized mice, but not in those of
BSA-immunized mice (Figure 3). The immunohistologic
patterns showed granular deposits along glomerular capillary
walls and in the mesangium. We also found complement C3
deposits in the glomeruli of C192S-immunized mice, but not
in those of BSA-immunized mice (Figure 4).
In APSGN, because the intrinsic mesangial, endothelial,
and epithelial cells proliferate and leukocytes infiltrate, the
number of cells in the glomeruli increases.10,20–22 We verified
leukocyte infiltration in the glomeruli. Immunohistochemi-
cal analysis showed myeloperoxidase (MPO)-positive stained
cells in the glomeruli of C192S-immunized mice, but not in
those of BSA-immunized mice (Figure 5). Anti-MPO
antibodies react with neutrophils and monocytes,23 showing
the localization of inflammatory cells (leukocytes and
macrophages).24 The MPOþ cells in glomeruli of C192S-
immunized mice reflected inflammatory cell infiltration.
Table 2 shows a comparative summary of the percentages of
glomeruli with IgG or C3 deposition and leukocyte
infiltration in C192S-immunized and BSA-immunized mice.
Urinary protein levels in SPE B-hyperimmunized mice
Many renal diseases involve proteins leaking from the
glomerulus. Low levels of protein are reabsorbed by tubular
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Figure 2 | Basement membrane thickening in the glomeruli of
mice hyperimmunized with 28-kDa SPE B mutant protein C192S.
BALB/c mice were (a, b) untreated or (c, d) hyperimmunized four
times with BSA or (e, f) C192S, and the kidney sections were stained
with Periodic acid-Schiff (n¼ 10 per group). The basement
membrane thickening is indicated by arrows. Original magnification:
a, c, and e,  200; b, d, and f  400.
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Figure 3 | Immunoglobulin deposits in the kidneys of mice
hyperimmunized with 28-kDa SPE B mutant protein C192S.
BALB/c mice were hyperimmunized four times with (a) BSA or
(b) C192S. Immunoglobulin deposits were detected using
FITC-conjugated anti-mouse IgG with fluorescence microscopy
(n¼ 10 per group). (c) The mean integral fluorescent intensity of
glomeruli was analyzed in 10 fields per mouse (n¼ 10 mice). Original
magnification  200.
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Figure 4 | Complement activation in the kidney of mice
hyperimmunized with 28-kDa SPE B mutant protein C192S.
BALB/c mice were immunized four times with (a) BSA or (b) C192S.
Complement C3 deposits were detected using FITC-conjugated
anti-C3d antibody with fluorescence microscopy (n¼ 10 per group).
(c) The mean integral fluorescent intensity of glomeruli was analyzed
in 10 fields per mouse (n¼ 10 mice). Original magnification  200.
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epithelial cells, but when protein levels are above the
reabsorption threshold, protein remains in the urine. We
found that hyperimmunization with C192S, but not with
BSA or SPE A, induced proteinuria (Figure 6a). The ratio of
albuminuria:creatinine in the urine of C192S-immunized
mice was elevated compared to the ratio in BSA- and SPE
A-immunized mice (Figure 6b). The number of mice
with hematuria is shown in Table 2.
Monoclonal anti-SPE B antibody 10G binds to mouse
glomerular endothelial cells and causes kidney injury and
proteinuria
There are two forms of antibody-associated kidney injury.
One is caused by antibodies reacting with glomerular
antigens, and the other is caused by deposits of immune
complexes.25 To further directly investigate the role of anti-
SPE B in glomerulonephritis, we generated a panel of
monoclonal antibodies. One of these clones, 10G, showed
high-binding activity with normal mouse kidney tissue.
Colocalizing 10G with anti-CD31 antibody confirmed the
binding of 10G to endothelial cells (Figure 7). Another clone,
9C, which did not bind to kidney tissue was used as a
negative control. Furthermore, we found antibody deposits
and complement activation in the glomeruli of mice
intravenously immunized with 10G, but not in those of
mice immunized with 9C (Figure 8). Urine protein levels and
albuminuria:creatinine ratios were higher in mice passively
immunized with 10G than in normal controls and mice
immunized with 9C (Figure 9).
Endothelial cell membrane proteins recognized by
anti-SPE B antibody
In order to confirm a mechanism of molecular mimicry, we
investigated whether there were autoantigens on the
endothelial cell surface. Membrane proteins from HMEC-1
cells were prepared and separated using two-dimensional gel
electrophoresis (2-DGE) with isoelectric focusing (pH 4–7)
(Figure 10a) and then analyzed using Western blotting
(Figure 10b and c). By comparing the Western blots from
samples with anti-SPE B sera (Figure 10b) and 10G
monoclonal antibody (Figure 10c) with those from samples
with anti-BSA sera (Western blot not shown; spots are
indicated by yellow circle a) or 9C monoclonal antibody
(Western blot not shown; spots are indicated by yellow circle
a–c), 16 protein spots were selected for further analysis
(Figure 10a). We used liquid chromatography/tandem mass
spectrometry to identify proteins and then searched the
NCBI and Swiss-Prot protein sequence databases (Table 3).
The target proteins recognized by both anti-SPE B sera and
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Figure 5 | Leukocyte infiltration in the kidney of mice
hyperimmunized with 28-kDa SPE B mutant protein C192S. BALB/
c mice were hyperimmunized four times with (a) BSA or (b) C192S.
Leukocyte infiltration was detected using anti-MPO antibody with
fluorescence microscopy (n¼ 10 per group). (c) The mean integral
fluorescent intensity of glomeruli was analyzed in 10 fields per mouse
(n¼ 10 mice). Original magnification  200.
Table 2 | Immunopathological and urinary findings in mice after immunization with BSA and C192S
Glomeruli (positive/total counted) (ratio) Urine (positive/mouse number)
Treatment group lgG C3 MPO Hematuria
BSA 15/183 (0.08) 17/163 (0.10) 8/125 (0.06) 0/8
C192S 141/194 (0.74) 122/181 (0.67) 95/162 (0.59) 4/6
BSA, bovine serum albumin; IgG, immunoglobulin G; MPO, myeloperoxidase.
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* P<0.05 as compared with BSA– or SPE A–immunized mice.
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Figure 6 | Proteinuria of mice after immunization with 28-kDa
SPE B mutant protein C192S. BALB/c mice were untreated (n¼ 8)
or immunized four times with BSA (n¼ 8), SPE A (n¼ 5), or C192S
(n¼ 7). Proteinuria was determined (a) using a protein assay kit
(***Po0.001) or (b) the albuminuria and creatinine ratio.
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10G antibody were heat shock protein 70 (HSP70) (spots
4–8) and thioredoxin (spot 15).
DISCUSSION
A large number of cases of glomerulonephritis are associated
with immune complex deposits and complement activa-
tion.10,26 The mechanisms of IgG deposition may be the
autoantibodies to the glomerular epitopes, deposits of
formerly circulating immune complex, or antibodies to the
deposited antigens. The precise mechanisms of APSGN
induced by GAS infection remain unclear, although the
clinical characteristics indicate that immune responses are
involved in renal injury. In this study, we showed that either
active immunization with SPE B mutant C192S or passive
immunization with anti-SPE B antibody caused pathologic
changes in mouse kidneys. After active immunization, we
found immunoglobulin deposits, complement activation,
and leukocyte infiltration in kidney glomeruli, which
indicated that the deposited anti-SPE B antibody may induce
renal inflammation and injury. This possibility was further
supported by our findings after passive immunization. These
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Figure 7 | Colocalization of monoclonal anti-SPE B antibody 10G with endothelial cell marker CD31 in mouse kidney sections.
Healthy mouse kidney sections were first stained with 9C (a–c) or 10G (d–f) antibody and rat anti-mouse CD31 (b, e) and then with
TRITC-conjugated anti-mouse IgG and FITC-conjugated anti-rat IgG, and were analyzed using confocal microscopy. Colocalization of 10G with
endothelial cell marker CD31 is shown (Merge; c, f). Original magnification  400.
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Figure 8 | Immunoglobulin deposition and complement
activation in mice after passive immunization with monoclonal
anti-SPE B antibody 10G. BALB/c mice were intravenously
immunized each day with 500 mg of monoclonal 9C or 10G IgG
for 3 days and, after 7 days, the kidney sections were analyzed using
(a, c) FITC-conjugated anti-mouse IgG or (b, d) anti-C3d antibody
(n¼ 3 per group). Original magnification  200.
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Figure 9 | Proteinuria in mice passively immunized with
monoclonal anti-SPE B antibody 10G. BALB/c mice were untreated
or intravenously immunized with 500 mg of monoclonal 9C or 10G
IgG (n¼ 6 per group) and, after 24 h, proteinuria was determined
(a) using a protein assay kit (*Po0.05) or (b) the albuminuria and
creatinine ratio.
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results, therefore, suggested a mechanism of molecular
mimicry in APSGN in which anti-SPE B antibodies cross-
react with glomerular basement endothelial cells and induce
tissue damage. A recent study5 reported that zymogen/SPE B
was likely to be the nephritogenic antigen involved in the
pathogenesis of most cases of APSGN. These two mechan-
isms are not mutually exclusive. The pathologic changes may
be resulted from the deposition of anti-SPE B antibodies
reactive with endothelial cells and with SPE B (C192S) in the
glomerulus, both will lead to complement activation,
inflammation, and injury.
Because wild-type SPE B is autocatalytic, we used the
protease-negative mutant 28-kDa C192S18 to hyperimmunize
mice both for active immunization experiments and for
generating monoclonal antibodies. What we found suggested
that protease activity is not essential for the onset of APSGN.
Nevertheless, whether SPE B protease activity contributes to
the disease needs further investigation.
In this study, we found complement activation in the
glomeruli of C192S-hyperimmunized mice. Renal inflamma-
tion might attract leukocyte infiltration. Clinically, APSGN
patients have a higher-than-normal number of macrophages
and neutrophils in the glomeruli.22 We also found leukocyte
infiltration in mouse glomeruli after SPE B hyperimmuniza-
tion. SPE B and its precursor isolated from nephritogenic
streptococci induced rat mesangial cells to proliferate and to
express intercellular adhesion molecule-1, as well as to
increase chemokine production, including monocyte che-
moattractant protein-1 and macrophage inflammatory pro-
tein-2.27 The production of chemokines may attract
leukocytes into the glomeruli. In children with APSGN,
monocyte chemoattractant protein-1 and interleukin-8 levels
in serum and urine were significantly higher during the acute
phase.28 Further studies are required to detect the chemo-
kines present in the glomeruli of hyperimmunized mice.
Injecting rats intrarenally with SPE B and its precursor
increased leukocyte infiltration in the glomeruli.29 In
addition, SPE B and its precursor were in the tissue-cage
model for APSGN during GAS infection with all strains.30 In
this study, we found that anti-SPE B antibody caused kidney
damage via molecular mimicry of glomerular endothelial cell
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Figure 10 | Identification of endothelial cell membrane proteins
recognized by anti-SPE B antibodies. (a) A 2-DGE proteome map of
HMEC-1 membrane proteins showing 16 protein spots selected to be
identified. (b, red circle) 2-DGE immunoblot profiles of HMEC-1
membrane proteins with anti-SPE B sera (c, blue circle), 10G
monoclonal antibody (yellow circle a, blot not shown), anti-BSA sera,
or (yellow circle a–c, blot not shown) 9C monoclonal antibody.
Table 3 | HMEC-1 membrane proteins recognized by anti-SPE B antibodies
No. Protein name Theoretical Mr/pI MO score Accession no.
1 Oxygen-regulated protein precursor 111266/5.2 95 gi| 5453832
2 Oxygen-regulated protein precursor 111266/5.2 187 gi| 5453832
3 Cytokeratin-1 65978/8.2 452 gi| 1346343
4 Heat shock 70-kDa protein 8 isoform 1 70854/5.4 333 gi| 5729877
5 Heat shock 70-kDa protein 8 isoform 1 70854/5.4 793 gi| 5729877
6 Heat shock 70-kDa protein 9 73682/6.0 275 gi| 12653415
7 Heat shock 70-kDa protein 9B precursor 73635/5.9 1699 gi| 24234688
8 Heat shock 70-kDa protein 9 73682/6.0 579 gi| 12653415
9 Tubulin-b 49640/4.7 970 gi| 18088719
10 Tubulin-b 49640/4.7 1710 gi| 18088719
11 Laminin-binding protein 31774/4.8 254 gi| 34234
12 Laminin-binding protein 31774/4.8 276 gi| 34234
13 GTP binding protein 1, isoform CRA_a 63562/6.4 47 gi| 119580665
14 a-1 (III) Collagen 96442/9.2 50 gi| 930045
15 Thioredoxin (reduced form), chain 11700/4.8 119 gi| 230939
16 b-Galactoside-binding lectin precursor 14706/5.3 112 gi| 4504981
SPE B, streptococcal pyrogenic exotoxin B.
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antigens. Therefore, anti-SPE B antibody may contribute to
the pathogenesis of APSGN that involves an autoimmune
mechanism. We identified several endothelial cell membrane
molecules recognized by anti-SPE B antibodies. Two of them,
the HSP70 and thioredoxin, were recognized by both anti-
SPE B sera and 10G monoclonal antibody. HSPs are highly
conserved, and their biological functions include cytoprotec-
tion, protein assembly, folding, and translocation. In
addition, HSPs may act as autoantigens.31 Proinflammatory
cytokines increased HSP70 expression in rheumatoid arthri-
tis synovial tissue.32 Moreover, HSP70 is found at the cell
surface and may contribute to the development of auto-
immune diseases.33 Thioredoxins act as protein disulfide
reductases, are involved in the redox regulation of transcrip-
tion factors, and are present in different compartments:
cytosol, nuclear, membrane associated, and extracellular.34,35
Abnormal thioredoxin expression has been correlated with a
number of human diseases.35,36 Whether the recognition of
HSP70 and thioredoxin by anti-SPE B antibodies is involved
in the pathogenesis of APSGN needs further investigation.
In summary, we showed that (1) SPE B hyperimmunization
caused pathologic changes in mouse kidneys; (2) immuno-
histochemical analysis of mouse kidney tissue revealed anti-
body deposits, complement activation, and leukocyte
infiltration, which is consistent with clinical features found
in APSGN patients; (3) a monoclonal anti-SPE B antibody
clone, 10G, was bound to glomerular endothelial cells; (4)
passively immunizing mice with anti-SPE B antibody also
caused renal injury; and (5) HSP70 and thioredoxin were
recognized by anti-SPE B antibodies and may act as
autoantigens. Thus, our study indicates that anti-SPE B
antibody may be involved in the pathogenesis of APSGN.
MATERIALS AND METHODS
Preparing recombinant SPE B and its mutant C192S
Recombinant SPE B and a C192S mutant lacking protease activity
were prepared as described previously.17,18 Briefly, the genomic
DNA of GAS was extracted and the pro-SPE B gene was amplified
using polymerase chain reaction with the sense primer 50-
GGATCCGGATCCCATCATCATCATCATCATGATCAAAACTTTGC
TCGTAACGAA-30 with a His6 tag and BamH1 recognition, and
with the antisense primer 50-GGATCCGGATCCCTAAGGTTTGA
TGCCTACAACAG-30 with BamH1 recognition. The polymerase
chain reaction product was purified and then cloned into the
BamH1 site of pET-21a vector. The recombinant plasmid was
transformed into Escherichia coli BL21 (DE3) pLyS strain, and the
system was under the control of a strong T7 promoter. The wild-
type construct was further used to produce a C192S mutation using
overlap extension polymerase chain reaction. The recombinant
protein was produced by growing cells at 281C overnight in LB
medium containing 10 g/l of Bacto tryptone, 5 g/l of Bacto yeast
extract, and 10 g/l of NaCl. The protein was then purified using
Ni2þ -chelating chromatography (Amersham Biosciences, Uppsala,
Sweden). The 40-kDa C192S protein was concentrated using
Amicon ultrafiltration with a 10-kDa cutoff membrane and
exchanged with phosphate-buffered saline (PBS). The 28-kDa
C192S was obtained from the 40-kDa C192S mutant zymogen
using trypsin cleavage.
Immunization protocol
The 8- to 10-week-old progeny of BALB/c mice, purchased from
The Jackson Laboratory (Bar Harbor, ME, USA), were used in this
study. The mice were intraperitoneally injected with 50 mg of 28-kDa
recombinant SPE B mutant C192S in complete Freund’s adjuvant
and then given two immunizations of C192S (50 mg) in incomplete
Freund’s adjuvant every 2 weeks. The fourth immunization was an
intravenous injection of C192S (10 mg). The mice were killed 8 days
later. Mice immunized with BSA (Sigma Chemical Company,
St Louis, MO, USA) or SPE A (a gift from YH Lu, Department of
Microbiology and Immunology, National Cheng Kung University
Medical College, Tainan, Taiwan) were the controls. There were 10
mice in each group.
Generating monoclonal anti-SPE B antibody
To generate monoclonal antibodies, we immunized BALB/c mice as
described above and killed them 4 days after last injection. Western
blotting verified that the anti-C192S monoclonal antibody clones
10G and 9C recognized both wild-type SPE B and C192S mutant.
Three (for histopathology) or six (for proteinuria) mice per group
were passively immunized by intravenously injecting them with
500 mg of monoclonal 10G or 9C IgG.
Histopathology
Mouse kidney tissue was fixed in 10% neutral-buffered formalin
solution and then dehydrated in graded alcohol. The fixed tissue was
embedded in paraffin and sliced into 4-mm-thick sections. The tissue
sections were mounted on regular glass slides and stained with
hematoxylin–eosin or Periodic acid-Schiff.
Immunohistochemistry staining
After they had been fixed for 24 h in 3.7% formaldehyde and
deparaffinized, the tissue sections were incubated in the unmasking
fluid MARK2 buffer (Serotec Ltd, Oxford, UK) at 921C for 10 min.
The tissue sections were blocked using 10% BSA/PBS, and then
using 1 mol/l of NH4Cl to reduce autofluorescence before adding
primary antibody. Adequately diluted primary antibodies in anti-
body diluents (DAKO Corporation, Carpinteria, CA, USA) were
then applied to the sections and incubated at 41C overnight. The
sections were washed in 0.05% PBS-Tween 20 and then incubated
with FITC- or TRITC-labeled secondary antibodies at room
temperature for 1 h. IgG deposits were detected using FITC-
conjugated goat anti-mouse IgG antibody (Jackson Immuno-
Research Laboratories Inc., West Grove, PA, USA). Complement
C3 was detected using sheep anti-human C3d (Serotec Ltd), which
cross-reacts with mouse C3d, and then using FITC-conjugated goat
anti-sheep IgG antibody (Jackson ImmunoResearch Laboratories
Inc.). Double immunofluorescence staining with anti-SPE B and
anti-CD31 was detected using monoclonal anti-SPE B antibody, 10G
or 9C, and rat anti-mouse CD31, and then using TRITC-conjugated
goat anti-mouse IgG and FITC-conjugated goat anti-rat IgG
(Jackson ImmunoResearch Laboratories Inc.). Leukocyte infiltration
was detected using anti-MPO antibody (Santa Cruz Biotechnology
Inc., Santa Cruz, CA, USA), and then using FITC-conjugated anti-
goat IgG (Jackson ImmunoResearch Laboratories Inc.). The mean
integral intensity of glomeruli in the fluorescent microscope field
was analyzed using image analysis software (Analysis Five; Olympus
Corp, Tokyo, Japan). The glomeruli in 10 fields (original
magnification  200) of each mouse sample (n¼ 10 mice) were
measured.
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Proteinuria assay
Mouse urine was collected 7 days after the last four active SPE B
immunizations and 24 h after the passive immunization with anti-
SPE B antibodies. Total urinary protein was determined using a
protein assay kit (Bio-Rad Laboratories Inc., Hercules, CA, USA).
Briefly, the urine sample was diluted with PBS, and then 100 ml of
diluted sample and 25 ml of dye reagent were added to each well of
the microtiter plate. After the samples had been incubated at room
temperature for 5 min, their absorbance was measured at 595 nm
using a microplate reader. Urinary microalbumin and creatinine
were measured using Beckman Immage System (Beckman Coulter,
Brea, CA, USA) in the Department of Pathology of National Cheng
Kung University Hospital. The results of microalbumin and
creatinine are presented as mg/dl. The collected urine was further
centrifuged for a microscopy hematuria examination.
Cell culture
HMEC-1 cells were incubated in culture plates containing Medium
200 (Cascade Biologics Inc., Portland, OR, USA) supplemented with
2% FBS, 1 mg/ml hydrocortisone, 10 ng/ml epidermal growth factor,
3 ng/ml basic fibroblast growth factor, 10 mg/ml heparin, and
antibiotics.
Extracting endothelial cell membrane proteins
Endothelial cell membrane proteins were isolated using a kit
(ProteoExtract Subcellular Proteome Extraction kit; Merck KGaA,
Darmstadt, Germany). Fraction II was the membrane protein
fraction to be analyzed using 2-DGE.
Two-dimensional gel electrophoresis
Fraction II was mixed with 11% TCA/acetone (1:9) containing
20 mM of DTT. After centrifugation at 10 000 g for 15 min, the pellet
was collected, washed twice using acetone with 20 mM DTT, and
resolved with rehydration buffer (7 M urea, 2 M thiourea, 2% CHAPS,
0.5% IPG buffer, 0.002% bromophenol blue, and 20 mM DTT) for
isoelectric focusing. The prepared fraction II (150 ml) was applied to
the immobilized pH gradient (IPG) strips (Immobiline DryStrip pH
4–7, 18 cm; Amersham Pharmacia Biotech Inc., Piscataway, NJ,
USA) in a strip holder and then focused for a total of 33.98 kVh
(Rehydration: 16 h at 30 V; Isoelectric focusing: 1 h at 500 V, 1 h at
1000 V, and 8 h at 8000 V linearly) using a kit (Ettan IPGphor II IEF
System; Amersham Pharmacia Biotech Inc.). After the isoelectric
focusing was finished, the strips were equilibrated with 10 mg/ml
DTT and 40 mg/ml iodoacetamide in equilibration buffer (6 M urea,
2% sodium dodecyl sulfate, 30% glycerol, 0.002% bromophenol
blue, 50 mM Tris–HCl, pH 8.8) for 15 min. After equilibration, the
strips were placed onto sodium dodecyl sulfate-polyacrylamide gel
electrophoresis gradient gels and sealed with 0.5% agarose. Gels
were run at 100 V for 10 min for the initial migration, and increased
to 300 V for separation. The 2-DGE gels were used for silver staining
and Western blotting.
Silver staining
2-DGE gel was fixed in 250 ml of fixation solution (105 ml 95%
ethanol and 25 ml acetic acid in ddH2O) for 30 min or overnight,
and then incubated in 250 ml of sensitization solution (79 ml 95%
ethanol, 0.78 g sodium thiosulphate, and 17 g sodium acetate in
ddH2O) for 30 min. After it had been washed with ddH2O, the
sensitized gel was incubated with 250 ml of silver solution (0.1 ml
formaldehyde (37%) and 0.625 g silver nitrite in ddH2O) for 25 min.
After it had been washed again, the gel was developed in 250 ml of
developing solution (0.05 ml formaldehyde (37%) and 6.25 g
Na2CO3 in ddH2O) and then stopped using three changes of 6%
acetic acid. The gel was then washed and kept in ddH2O.
Western blotting
Proteins separated using 2-DGE or sodium dodecyl sulfate-
polyacrylamide gel electrophoresis were transferred to polyvinyli-
dene difluoride membranes (Immobilon-P, 0.45 mm; Millipore
Corporation, Billerica, MA, USA) using a semi-dry electroblotting
system. After they had been blocked using 5% skim milk in PBS,
the membranes were incubated with anti-SPE B or anti-BSA sera
(1/5000 dilution) and 10G or 9C antibodies (1/2500 dilution) at
41C overnight. After they had been washed with 0.05% PBS-Tween
20, the membranes were incubated with a 1/5000 dilution of anti-
mouse IgG at room temperature for 30 min. After they had been
washed, the membranes were soaked in ECL solution (Western
Lightning kit; PerkinElmer Life Sciences Inc., Boston, MA, USA) for
1 min. Then the membrane was exposed to light film (BioMax;
Eastman Kodak, Rochester, NY, USA) to reveal specific proteins.
Spot analysis and mass spectrometry
The spots were digitalized using an image scanner (Power Look III
with LabScan software version 5; Amersham Biosciences) and the
acquired images were then analyzed (Image Master 2D version
2002.01; Amersham Biosciences). The specific molecular weights
and isoelectric points (pI) of spots were calibrated from gel images.
In-gel digestion of protein spots from silver-stained gels and further
protein identification using liquid chromatography/tandem mass
spectrometry was carried out by the Proteomics Research Core
Laboratory, National Cheng Kung University Medical College. The
samples were analyzed using mass spectrometry (LCQ DECA XP
Plus Ion Trap Mass Spectrometer; ThermoFinnigan, San Jose, CA,
USA). The proteins were identified by peptide fragmentation
pattern using the tandem mass spectrometry ion search of the
Mascot program (http://www.matrixscience.com/) in the NCBI and
Swiss-Prot protein sequence databases.
Statistics
We used the paired t-test for statistical analysis. Statistical
significance was set at Po0.05.
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